*EISAI-E2007-G000-235




A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics When Administered as an Adjunctive Therapy in Adolescents (12 to Less Than 18 Years of Age) With Inadequately Controlled Partial-onset Seizures
perampanel
E2007-G000-235
NCT01161524
EU CTR 2010-018518-56
Epilepsy
Phase 2
 
No restrictions.
November 2018